MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Exposure-Response Analysis of Glovadalen in the ATLANTIS Phase II Study: Trial Simulation Explains Dose-Response for OFF Time in Parkinson’s

    D. Menshykau, M. Biagioni, C. Beuter, C. Legendre, A. Benoit, L. Vroye, B. Klünder, M. Faisal, S. Leach, R. Nicholl, H. Naik (Monheim am Rhein, Germany)

    Objective: This analysis characterized the exposure-response (E-R) relationship of glovadalen (UCB0022) in the ATLANTIS Phase-IIa proof-of-concept study, to understand the apparent lack of dose-response for…
  • 2026 International Congress

    Affective Symptom Burden in Individuals with Olfactory Dysfunction in the PREDICT-PD Cohort

    A. Shahid, S. Waters, S. Meyer, H. Chohan, V. Azoidou, C. Simonet, L. Pérez-Carbonell, E. De-Pablo Fernandez, A. Schrag, A. Noyce (London, United Kingdom)

    Objective: To investigate associations between hyposmia (olfactory dysfunction) and affective symptom burden in PREDICT-PD participants. Background: Anxiety, depression, and hyposmia are common non-motor features of…
  • 2026 International Congress

    Long-term outcomes and real-world implementation of adaptive deep brain stimulation in Parkinson’s disease

    V. Witzig, J. Busch, J. Kaplan, J. Behnke, L. Drescher, J. Habets, A. Kühn (Berlin, Germany)

    Objective: To evaluate long-term outcomes and real-world implementation of beta-guided adaptive deep brain stimulation (aDBS) in patients with Parkinson’s disease (PD), including clinical effects, longitudinal…
  • 2026 International Congress

    Real-World Relationship Between Beta-Band LFP Activity and Motor States in Parkinson’s Disease

    IMV. Martin, DRM. Rodriguez-Martin, SM. Marco, BT. Tijero, TF. Fernández, RDP. Del Pino, MA. Acera, JCG. Gómez-Esteban, MRL. Ruiz-López (Cornellà de Llobregat, Spain)

    Objective: To evaluate the relationship between 10-minute averaged beta-band local field potential (LFP) activity recorded from implanted deep brain stimulation (DBS) systems and motor state…
  • 2026 International Congress

    The Unholy Marriage Between Ogilvie Syndrome and Parkinson’s Disease

    Y. Zashchypas, S. Lorenzl (Salzburg, Austria)

    Objective: To demonstrate the dynamic interplay between advanced Parkinson’s disease (PD)–related colonic dysmotility and acute colonic pseudo-obstruction (ACPO; Ogilvie syndrome) and to highlight practical red…
  • 2026 International Congress

    Comparability of Smartphone App and Booth Recordings for Robust Acoustic Speech Monitoring in Parkinson’s Disease

    T. Thies, J. Strelow, D. Lopez, J. Tröger, I. Rubi-Fessen, M. Barbe, D. Mücke (Cologne, Germany)

    Objective: To assess the technical equivalence and scalability of remote app-based recordings against gold-standard laboratory conditions to identify reliable speech features suitable for longitudinal monitoring…
  • 2026 International Congress

    A Case of Progressive Cerebellar Syndrome with Ataxia as a First Sign

    J. Mateo, A. Tamayo (Callao, Peru)

    Objective: To present a case of paraneoplastic cerebellar degeneration whose first sign was ataxia. Background: Paraneoplastic cerebellar degeneration (PCD) is a rare autoimmune syndrome that presents…
  • 2026 International Congress

    App-Based Speech Assessment Differentiates PD and PSP: A Feasibility Study in Italian Speakers

    T. Thies, S. Cuoco, M. Autuori, A. Sahay, J. Tröger, M. Picillo (Saarbrücken, Germany)

    Objective: To evaluate the feasibility of app-based speech assessment in Parkinson’s disease (PD) and progressive supranuclear palsy (PSP), and to explore group differences in speech…
  • 2026 International Congress

    Clinical and Biomarker Trajectories in GBA1 Non-Manifesting Carriers With and Without α-Synuclein Seed Amplification Positivity

    P. Gonzalez-Latapi, S. Brooker, C. Gochanour, M. Brumm, K. Merchant, R. Alcalay, T. Simuni (Chicago, USA)

    Objective: To characterize clinical and biomarker features of GBA1-NMC and evaluate whether CSF-αSynSAA status is associated with longitudinal clinical progression and phenoconversion. Background: Pathogenic variants…
  • 2026 International Congress

    Does CANVAS mimic MSA-C

    I. Pei, A. Storck, T. Bogdan, C. Tranchant, IJ. Namer, S. Kremer, T. Thomas, M. Anheim (Strasbourg, France)

    Objective: To describe the natural history of RFC1-related ataxia, identify discriminative features compared to MSA-C, and study their survival outcomes. Background: AAGGG intronic expansions in…
  • « Previous Page
  • 1
  • …
  • 145
  • 146
  • 147
  • 148
  • 149
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley